A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
SVNT will market it's new gout medicine in Dec. It needs money soon (bummer) but can probably get it (cool) though that MIGHT dampen price (possible bummer). The bad news is all in the price (cool) and it MIGHT find a buyer after all (cool) or successfully market its much praised in advance med (cool). On balance, the chart and "story" look sideways followed by up. #